DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Conditions
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Research Site, Hefei, Anhui, China
Research Site, Beijing, Beijing Municipality, China
Research Site, Beijing, Beijing Municipality, China
Research Site, Guangzhou, Guandong, China
Research Site, Guangzhou, Guandong, China
Research Site, Zhengzhou, Henan, China
Research Site, Wuhan, Hubei, China
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, Jiangsu, China
Research Site, Changchun, Jilin, China
Research Site, Dalian, Liaoning, China
Research Site, Shenyang, Liaoning, China
Research Site, Jinan, Shandong, China
Research Site, Linyi, Shandong, China
Research Site, Shanghai, Shanghai Municipality, China
Research Site, Taiyuan, Shangxi, China
Research Site, Tianjin, Tianjin Municipality, China
Research Site, Tianjin, Tianjin Municipality, China
Study leads
Jianyong Li
Principal Investigator
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital